Tubeimoside I, CAS [[102040-03-9]]

Produktübersicht

• Artikelname: Tubeimoside I, CAS [[102040-03-9]]
• Artikelnummer: MCE-HY-N0890
• Hersteller Artikelnummer: HY-N0890
• Alternativnummer: MCE-HY-N0890-25MG,MCE-HY-N0890-10MMX1ML,MCE-HY-N0890-10MG,MCE-HY-N0890-5MG,MCE-HY-N0890-50MG,MCE-HY-N0890-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Tubeimoside-1, Lobatoside-H

Produktbeschreibung

Tubeimoside I is an orally active HSPD1 inhibitor. Tubeimoside I inhibits NF-kappaB, MAPK, as well as regulates eNOS-VEGF. Tubeimoside I induces cytoprotective Autophagy via an Akt-mediated pathway. Tubeimoside I inhibits proinflammatory cytokine (IL-6 and IL-1beta) production. Tubeimoside I exhibits anti-inflammatory activities. Tubeimoside I promotes angiogenesis and improves sepsis symptoms. Tubeimoside I is used in the research of inflammatory diseases, various cancers, sepsis and ischemic diseases[1][2][3][4][5][6][7][8][9][10][11].

Produkteigenschaften

• Molekulargewicht: 1319.43
• Reinheit: 99.96
• CAS Nummer: [102040-03-9]
• Formel: C63H98O29
• Target-Kategorie: Akt,Autophagy,HSP,Interleukin Related,NF-kappaB,p38 MAPK,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Natural Products